data for both treatments are still insufficient. The aim of the present study was to evaluate the treatment of parasagittal meningiomas and provide evidence that a multimodal treatment approach reduces complication rates and achieves good tumor control rates. Our patient series provides long-term follow-up data after microsurgery alone, radiosurgery alone, or the two combined for parasagittal meningiomas of all WHO grades with follow-up times that are among the longest reported. 16, 21, 22 
Methods

Patient Sample and Data Evaluation
One hundred seventeen patients were treated for parasagittal meningiomas between 1993 and 2013 at the Department of Neurosurgery, Medical University Vienna. However, the first microsurgical resection in 8 patients treated in this time frame dated back to the 1980s. All radiosurgical and the majority of microsurgical procedures had been performed in our department. Few patients had undergone prior microsurgical resection elsewhere before they were referred to us for a second microsurgery and radiosurgery. The only exclusion criterion was a total lack of archived documentation. Patients who were lost to followup were included in the study but were excluded from the outcome analysis. Data were evaluated retrospectively. Fifty-three cases (45%) were treated with microsurgery alone. Radiosurgery was performed in 64 cases (55%) either as part of a combined microsurgery-radiosurgery treatment approach (53 cases [45%]) or as the sole modality (11 cases [9%], presumed meningioma). Seventeen (14%) of the 117 patients also received radiation therapy during the course of their disease. Thirteen patients (11%) underwent additional microsurgical resection of meningiomas at localizations other than the parasagittal and/or superior sagittal sinus. Patient and tumor characteristics are presented in Table 1 . Patients were rated according to the Karnofsky Performance Scale (KPS) prior to microsurgery and GKRS and at the time of follow-up. 10 Superior sagittal sinus invasion and/or occlusion and Simpson resection grade were assessed using the following methods: preoperative and postoperative contrast-enhanced T1-and T2-weighted MRI, including MR angiography; CT angiography, if available; and/or surgical reports. In some cases, digital subtraction angiography data were also available. 23 At follow-up, brain MRI studies were evaluated, and the status of the treated meningioma was rated as stable, regression, or progression. Progression was diagnosed if the largest tumor diameter had increased by more than 20%. 29 This study was approved by the ethics review committee of the Medical University Vienna.
Radiosurgical Technique
Radiosurgery was performed with a Leksell Gamma Knife (Model B until 2011 and Perfexion from 2012 onward, Elekta AB). GammaPlan (Elekta AB) was used as planning software. Magnetic resonance imaging planning sequences were obtained on a 1.5-T magnet. Gadolinium contrast-enhanced T1-weighted and T2-weighted MR scans, as well as contrast-enhanced and bone window CT scans, were used in the treatment planning. The target was defined as a contrast-enhanced tumor mass on T1 sequences and as a hypointense tumor mass on T2 sequences. Whole tumor mass including the T1 contrast-enhanced dural tail was covered without an additional margin. Gamma Knife radiosurgical parameters are outlined in Table 2 . The majority of patients (52 [81%]) underwent single GKRS for parasagittal meningioma. Eight patients (13%) were treated twice, and 4 patients (6%) were treated a third time, albeit at nonoverlapping treatment areas. Of note, 13 (11%) of 117 patients had radiosurgery for additional meningiomas at localizations other than the parasagittal and/or superior sagittal sinus.
Radiation Therapy Technique
Linear accelerator (LINAC)-based irradiation of the tumor cavity with 54-60 Gy was performed after microsurgical resection regardless of resection status. The target was defined based on the premicrosurgery contrast-enhanced MRI coregistered to postmicrosurgery contrast-enhanced planning MRI and CT scan with a slice thickness of 2 mm. The clinical target volume was defined as the premicrosurgery tumor extension adapted to the postmicrosurgery anatomy with a meningeal safety margin of 2 mm to account for microscopic tumor extension. The planning target volume was defined as an additional 5-mm isotopic margin according to the institutional protocol. A typical fractionation schedule for adults was 1.8-2 Gy per day for 5 days a week for 6 weeks.
Statistical Analysis
Statistical calculations included the Wilcoxon signedrank tests for paired samples and the Kruskal-Wallis, Mann-Whitney U-, and chi-square tests for independent samples. In cases of multiple testing, Bonferroni-Holm or Shaffer's procedure was used as appropriate. Survival and time-to-progression data were estimated according to the Kaplan-Meier method and were compared using the pairwise generalized Wilcoxon-Breslow test. A p value < 0.05 was considered statistically significant. The SPSS 23.0 software (IBM Corp.) was used.
Results
Patient Presentation and Microsurgical Technique
Patients predominantly presented with seizures, hemiparesis, or headache at diagnosis (Table 1) . Several patients (13 [24%] of 53) underwent multiple surgeries prior to the first GKRS or as the sole treatment (4 [8%] of 53). In general, among patients in the microsurgery group, lesions were equally distributed along the superior sagittal sinus. In contrast, lesions treated with radiosurgery were frequently located at the central and frontal regions. Tumor volume at the first intervention was greatest in the combined-treatment group and smallest in patients treated with radiosurgery alone (p < 0.001). At the time of GKRS, the target volume of tumors that had already been treated with microsurgical resection still tended to be larger than tumors that were treated with radiosurgery alone (p = 0.087; Table 2 ).
Of the 117 patients, 49 (42%) were diagnosed with occlusion of the superior sagittal sinus at some point during their microsurgery or radiosurgery treatments. At the time of microsurgical resection, the incidence of invasion (p = 0.027) or occlusion (p = 0.010) of the superior sagittal sinus was significantly higher in the combined-treatment group than in the microsurgery-only group (Table 1) . There was a trend toward a higher rate of Simpson Grade III or IV resections in the combined-treatment group than in the microsurgery-only group (p = 0.076). Invasion of the superior sagittal sinus was significantly associated with Simpson Grade IV resection and subsequent radiosurgery treatment (p < 0.001). Complete sinus occlusion was followed by microsurgical resection of the occluded sinus in 20 (41%) of 49 patients, by tumor resection without resection of the sinus in 16 (33%) of 49 patients, and by GKRS in 13 (26%) of 49 patients. ‡ Superior sagittal sinus invasion or occlusion at the time of the first microsurgical resection appears in the first 2 columns and appears as aggregated data until the time of the first GKRS in the last column. Thus, the last column reflects data from cases involving multiple surgeries prior to GKRS with sinus occlusion at the first microsurgery or any time after the first microsurgery. § Several patients underwent multiple surgeries. For these cases, Simpson resection grade as reflected in the table is the one assigned after the last microsurgical resection. ¶ In cases with multiple surgeries and differing histopathological findings, the highest grade of diagnosed histology is provided for the microsurgery and combination groups.
Time to Recurrence After Microsurgery
Histopathological analysis revealed WHO Grade I tumors (75 [71%] of 106) in the majority of cases after the first microsurgical resection, followed by Grade II (27 [25%] of 106) and Grade III (4 [4%] of 106) tumors. However, after multiple surgeries, several patients were diagnosed with a WHO tumor grade higher than that after their first surgery (33%; Table 1 ). Atypical and malignant meningiomas were predominantly treated with the microsurgery-radiosurgery combination treatment (p = 0.009). All malignant meningiomas were treated with radiation therapy to the resection cavity after microsurgery and with radiosurgery for recurrent meningioma after radiotherapy. After the first microsurgical intervention, the resection status of 79 (74%) of 106 patients was graded as Simpson Grade I-III. Twenty-seven (25%) of the 106 patients underwent subtotal resection (Simpson Grade IV). Among patients who underwent total macroscopic tumor resection (Simpson Grades I-III), 37 (47%) had a recurrence. Time to recurrence in patients with WHO Grade I tumors was significantly longer than in patients with WHO Grade II or III meningiomas (Fig. 1A) .
In 6 (22%) of the 27 patients who had undergone Simpson Grade IV resection, residual tumors were treated with radiosurgery before progression could be diagnosed. In the remaining 100 patients, the time to recurrence or progression after the first microsurgery was 6.7 years (Simpson Grade I-IV, 95% CI 4.6-8.8 years) as estimated using the Kaplan-Meier method. There was a significant difference in time to recurrence or progression after microsurgery between patients with different Simpson resection grades when considering all WHO tumor grades ( Fig. 1B and C) . However, no significant difference was found in the time to recurrence or progression after microsurgery between patients with different Simpson resection grades when only benign meningiomas were evaluated.
Pre-Gamma Knife Treatment and Time to Radiosurgery
Among the 64 patients who were treated with radiosurgery, 11 (17%) were treated with radiosurgery alone whereas 53 (83%) were treated with both microsurgery and radiosurgery (Table 1) . Several patients (13 [20%] of 64) underwent multiple surgeries prior to GKRS. Following microsurgical resection, 32 patients (50%) had a recurrence; 21 patients (33%) who had undergone subtotal resection had a residual lesion that was treated at the first GKRS. At the second and third GKRS treatments, only recurrent lesions were irradiated at nonoverlapping areas ( Table 2 ). All patients with malignant meningiomas (WHO Grade III, 10 patients), 2 patients (13%) with WHO Grade II meningiomas, and 1 notable patient (4%) with Grade I meningioma underwent LINAC-based irradiation of the tumor cavity prior to the first GKRS treatment. The median time to GKRS after the last microsurgical intervention was 2.7 years (range 0.1-24.0 years). The time to radiosurgery was significantly longer (p = 0.002) if a recurrence was treated (3.4 years, range 0.3-24.0 years) than if a residual lesion was treated (1.0 year, range 0.1-12.8 years). In the radiosurgery-only group, the majority of patients were diagnosed with progressing lesions (8 [73%] of 11) prior to GKRS. In 3 patients (27%) no progression was noted prior to GKRS, but the meningioma was treated according to each patient's wishes. The median time between diagnosis and GKRS was 1.8 years (range 0.1-3.3 years).
Complications After Microsurgery and Radiosurgery
After microsurgical resection among the 106 patients, 15 (14%) experienced surgical complications and 5 patients (5%) experienced medical complications (Table 3 ). The surgical complications were managed conservatively in 5 patients (33%) and surgically in 10 (67%). Medical complications included pulmonary embolism, thrombosis, and pneumonia. Although not statistically significant, surgical complication rates were higher if a sinus resection or opening had been performed (18% vs 13% for subtotal resection). Postradiosurgery complications included radiation reaction and/or edema. Two (3%) of the 64 patients in the radiosurgery group experienced neurologically relevant postradiosurgery complications that could be managed conservatively.
Follow-Up and Overall Survival
Of the total 117 patients, 13 (11%) were lost to longterm clinical and radiological follow-up. In the remaining patients, the median follow-up was 7 years (range 1.1-33.3 years) from the first surgical intervention and 6 years (range 0.5-14.3 years) after radiosurgery. Moreover, 37% of patients had a follow-up > 10 years. In addition, we performed a death register comparison using data provided by Statistik Austria. Thus, we were able to determine that, by the last follow-up, 23 (20%) of 117 patients had died. As described above, 1 patient died of a pulmonary embolism after surgery. Seven (6%) of the 117 patients had died long after the last intervention because of medical causes not directly related to surgery and/or radiosurgery or tumor progression (for example, cancer, heart failure).
However, in 15 (13%) of the 117 patients, death was caused by tumor progression or was related to the meningioma diagnosis. Unsurprisingly, the majority of those patients
FIG. 1. A:
Kaplan-Meier estimates of time to recurrence after the first microsurgery in 79 patients who underwent total macroscopic tumor resection (Simpson Grade I-III); 37 (47%) had a recurrence. The median time to recurrence, as estimated using the Kaplan-Meier method, was 7.3 years (79 patients, 95% CI 4.8-9.8 years). More specifically, the time to recurrence for patients with WHO Grade I tumors was significantly longer (median 11.9 years, 95% CI 3.9-19.9 years) than that for patients with WHO Grade II meningiomas (median 4.1 years, 95% CI 1.5-6.6 years; p = 0.026) or Grade III meningiomas (median 1.5 years, 95% CI 0.8-2.3 years; p = 0.002). B: Kaplan-Meier estimates of time to recurrence or progression after the first microsurgery among patients who underwent Simpson Grade I-IV resections (100 of 106 patients), including all WHO tumor grades. Six of 106 microsurgery patients, who had undergone Simpson Grade IV resection, were treated with radiosurgery before progression was observed. A significantly (p = 0.038) shorter time to progression or recurrence was observed after pooled Simpson Grade III or IV resection (median 5.2 years, 95% CI 2.9-7.4 years) than after pooled Grade I or II resection (median 7.5 years, 95% CI 3.5-11.5 years). C: Kaplan-Meier estimates of time to recurrence or progression after first microsurgery, according to WHO grade (100 of 106 patients). Six of 106 microsurgery patients, who had undergone Simpson Grade IV resection, were treated with radiosurgery before progression was observed. The time to recurrence or progression was significantly longer among patients with WHO Grade I tumors (median 8. The overall 5-year survival rate, including deaths related and not directly related to the meningioma diagnosis, was 70%, 84%, and 97% after diagnosis of a WHO Grade III, Grade II, and Grade I meningioma, respectively.
Tumor Control Rates and Time to Progression After Radiosurgery
The majority of patients in the radiosurgery group (46 [72%] of 64) presented with stable or decreasing meningiomas at the last follow-up. More specifically, 15 patients (23%) were diagnosed with stable lesions and 31 (48%) with decreasing lesions. Four (6%) of the 64 patients were lost to follow-up, and 14 (22%) patients were diagnosed with a progressing lesion. A subgroup analysis among those 14 patients revealed that the median time to progression was 5.4 years (range 0.3-10.9 years; Fig. 1B) . Half of the patients (7 of 14) who presented with progressing meningiomas could be managed conservatively at the time of their last follow-up; however, the other half underwent resection for the lesion progression. Since the majority of cases in the radiosurgery group were treated with microsurgery and radiosurgery, we could correlate histopathological findings with follow-up status (Fig. 1D) . Unsurprisingly, patients presenting with progressing lesions were predominantly diagnosed with WHO Grade II or Grade III tumors (p = 0.027). Among patients treated with radiosurgery alone (presumed meningioma), only 1 patient (1 [9%] of 11) was diagnosed with a progressing meningioma that could be monitored. In summary, after a median follow-up of 6 years, we reported post-GKRS tumor control rates of 91% for presumed meningioma, 85% for benign meningioma, 71% for atypical meningioma, and 38% for malignant meningioma.
Discussion
Parasagittal meningiomas are still considered a microsurgical challenge. The optimal treatment thus far has been described as a Simpson Grade I resection, although this procedure can only be successfully achieved in fewer than 25% of patients because of invasion of the superior sagittal sinus. 22, 26 Even after radical resection, meningioma recurrence rates ranging from 8% to 13% have been reported. 3, 13, 16 In most cases, the venous sinus is only partially obstructed, thus preventing total tumor resection. Subtotal tumor resection has been associated with a significantly higher rate of tumor recurrence. 3, 4, 13 Several studies have shown that radiosurgery is a safe treatment option with adequate long-term tumor control rates. 16, 19, 21, 30 Our study provides data on microsurgery, radiosurgery, and combination treatment options at a single center. Limitations of our study include its retrospective character and single-center and treatment-biased nature. However, our median follow-up time of 6 years after radiosurgery and 7 years after microsurgery are among the longest reported follow-ups. Moreover, more than a third of our patients had follow-ups > 10 years. 12, 16, 21, 22 
Time to Progression After Microsurgery, Survival Rates, and Postradiosurgery Tumor Control Rates as Determined by WHO Grades
In our opinion, it is important to note up front that parasagittal meningioma patients are a heterogeneous group per se. This is reflected in the various treatments that patients received for their meningiomas including multiple surgeries (before and in some cases also after radiosurgery), radiotherapy, and radiosurgery. Several patients also underwent additional radiosurgical and/or microsurgical treatment for meningiomas at localizations other than the parasagittal and/or superior sagittal sinus. Moreover, as reflected in our study, tumor volume and localization as well as involvement of the venous sinus vary considerably and thus should a priori influence the treatment strategy. Furthermore, histopathological grade determines the need for further adjuvant treatment, as well as outcome and time to progression, as demonstrated by our current data as well as previously published data. 11, 28 Adjuvant treatments after microsurgical resection for atypical meningioma remain poorly defined. A recent study found no difference in the overall survival of atypical meningioma patients who received LINAC-based fractionated radiation therapy after microsurgical resection compared with those who did not. 1 However, in the same study, the time to recurrence was significantly longer in patients who received radiation therapy. 1 After several surgeries, a high percentage of patients (33%) in our series were diagnosed with atypical or malignant meningioma. 22, 27 This unusually high incidence of atypical and malignant meningiomas may be explained by the tertiary care status of the Medical University Hospital Vienna. 22, 27 All patients with malignant meningiomas and 2 patients with atypical meningiomas received fractionated radiation therapy of 54-60 Gy to the resection cavity after microsurgical resection and prior to the first GKRS. Despite this fact, malignant meningioma recurred in a significantly shorter time after microsurgery than the WHO Grade I or Grade II tumors. Thus, all malignant meningioma patients in our series were treated with a combination of microsurgery, radiotherapy, and radiosurgery. This multimodal treatment approach for malignant meningioma leads to a favorable 5-year survival rate, even in this particularly challenging subgroup. 2, 9 The 5-year survival rate for patients with benign tumors should be 100%, but 1 patient died of a pulmonary embolism a few days after microsurgical resection and 1 patient died of myocardial infarction 2 years after and unrelated to the microsurgical resection.
Several radiosurgery centers apply higher prescription doses to WHO Grade III tumors than to Grade I tumors. 5 Because of the overall pretreatment of these tumors in our series, we did not adjust our GKRS prescription doses according to WHO grade; instead, we adjusted the doses according to tumor volume, tumor localization, and the previously applied fractionated radiation dose. We report post-GKRS tumor control rates of 91% for presumed meningioma, 85% for benign meningioma, 71% for atypical meningioma, and 38% for malignant meningioma after a median follow-up of 6 years. Those tumor control rates are in agreement with the pertinent literature on intracranial meningiomas. Moreover, in our opinion, our presumed meningioma group represented ideal candidates for radiosurgery since the tumor volume was small and the overall clinical condition of the patients was good. 9, 18, 19, 21, 30 
Complications After Microsurgery Decreased With a Multimodal Treatment Approach
The radical microsurgical management of parasagittal meningiomas with invasion or occlusion of the venous sinus is associated with high complication risks and postoperative morbidity and mortality. Complete resection of the sinus can lead to brain swelling and death. 16, 19, 24, 27 Postoperative complication rates of 15%-20% have been described in recent studies. 7, 20, 27 In our series, surgical complications totaled 14%, while an additional 5% were identified as medical complications. Unfortunately, twothirds of patients with surgical complications had to be managed surgically; patients who required lumbar drains are included in this percentage. One patient died because of a postoperative pulmonary embolism after sinus resection; thus, we report a postoperative mortality rate of 0.9%. Surgical complications were higher after sinus resection or sinus opening than after subtotal tumor resection (18% vs 13%). Some studies favor complete resection with venous repair, while others favor subtotal tumor resection and subsequent radiosurgery. 16, 19, 24, 27 Radiosurgery-associated complications are directly related to target volume, location, prescription dose, and preexisting edema. Complication rates of up to 23% have been reported. 12, 14, 19, 22 In our well-selected series, a postradiosurgery complication rate of 3% was observed. Thus, in our opinion, a combined microsurgery-radiosurgery treatment approach improves postsurgical complication rates and patient outcomes.
Influence of Simpson Resection Grade on Time to Progression Among Benign Meningiomas
In our study, preoperative invasion of the superior sagittal sinus led to a higher rate of Simpson Grade IV resection and subsequent radiosurgery. 23 However, radiosurgery was part of the initial treatment strategy in only 6 cases. In the remaining cases, residual tumors were monitored and radiosurgery was performed only after radiological progression. Thus, most cases were available for analysis of time to recurrence or progression after microsurgical resection. The Simpson resection grade had a significant impact on time to progression or recurrence when Simpson Grade IV patients and all WHO tumor grades were considered. 7, 17 However, among patients who underwent total macroscopic tumor resection (Simpson Grades I-III), there was no significant difference in time to recurrence. Moreover, when benign meningiomas alone were considered, the Simpson resection grade did not have a significant impact on time to recurrence or progression. A recent study published similar results. Therefore, it is justifiable, in our opinion, to radiologically monitor residual benign meningiomas after subtotal resection and to radiosurgically treat those with documented progression. 27 However, in cases of larger residual tumor, radiosurgery should be applied in due course after microsurgery to avoid a high complication risk from further enlargement of the target volume. 22 Atypical and malignant meningioma residues and recurrences should be treated in any case.
Tumor control rates after radiosurgery for atypical meningiomas were satisfactory in our patient series and in other published series. 1, 6, 28 Treatment of malignant meningiomas should involve radiation therapy to the resection cavity. Malignant meningioma recurrence after microsurgical resection and radiation therapy can be safely treated with radiosurgery.
1,28
Conclusions
In our opinion, complications after microsurgery for parasagittal meningioma can be decreased with a multimodal treatment approach. Small residual tumor after subtotal microsurgical resection of benign meningiomas can be treated with radiosurgery or monitored radiologically until its progression and then treated with radiosurgery. Gamma Knife radiosurgery is a safe and effective treatment, especially for benign meningiomas. It can be administered as part of a multimodal treatment plan or also as a single treatment in selected patients. Larger residual tumor should be treated with radiosurgery in due course after microsurgical resection to avoid any further increase in target volume. Residual or recurrent atypical or malignant meningioma should be treated in any case. Radiosurgery is a safe treatment for recurrent malignant meningioma after microsurgical resection and fractionated radiation therapy. Thus, microsurgery, radiotherapy, and radiosurgery are complementary treatment options for parasagittal meningiomas.
